No significant difference was observed in apoptosis analyses of PDAC cell lines
The results showed that knockdown or forced overexpression of GRP78 did not influence apoptosis and death of PDAC cells without induction of UV rays or chemicals (Fig.S2 ). After knockdown of GRP78, the apoptosis rate of SU86.86 was (8.73±0.26)%, while the apoptosis rate of control group was (7.77±0.32)%, no significant difference was observed ( p = 0.078). Similar results were observed in BxPC-3 group (p = 0.096) and forced overexpression group (Capan-1, p = 0.539).
Verification of knockdown of GRP78 by three different siRNAs by western blotting. The knockdown of GRP78 was performed by using three different siRNAs. The sequences of the siRNAs were: siRNA-1, 5'-CUAUGAAGCCCGUCCAGAAtt-3'; siRNA-2, 5'-GAAUGAAUUGGAAAGCUAUTT-3'; siRNA-3, 5'-GGAGCGCAUUGAUACUAGATT-3'; Negative control, 5ʹ-UUCUCCGAACGUGUCACGUtt-3ʹ. Western blotting verified that siRNA-1 was the most effective one which was chosen for the further experiments ( Fig S3) .
Supplemental Material and Methods
Verification for specificity of anti-GRP78 antibody. Blocking peptide (ab176143, Abcam Biotech Company, Cambridge, UK) for anti-GRP78 antibody (ab108613, Abcam Biotech Company, Cambridge, UK) was used according to the manufacturers' protocol. For Western blotting of the whole protein of SU86.86 cell line, antibody and blocking peptide were added to dilution buffer at a dilution of 1:1000, incubate at room temperature for 30 minutes before reacting with the blot. For immunohistochemistry of PDAC tissues, twice the volume of peptide as volume of antibody was used. Positive control was performed without blocking peptide. 
